Pharmaceutical fakes: a dangerous pandemic A unified authentication system is needed to combat the massive trade in counterfeit medicines. …
Chris McGuigan: driving drug development Chris McGuigan, chairman of the Life Sciences Hub Wales, discusses the business side of research, his proudest invention and what the future holds for innovation in Wales.…
Personalised medicines — creating ‘polypills’ in the local pharmacy Patients require different combinations of drugs at different doses. Gino Martini explains how ‘polypills’ may enable patients to take one tablet containing the medicines and doses appropriate for them.…
Alternative antibiotic regimens effective for resource-poor settings A major research venture has yielded two antibiotic regimens for treating severe infections that can be administered in the outpatient setting.…
One in ten patients modify their medication to overcome swallowing difficulties In a survey of customers at five community pharmacies in Australia, 10.6% of respondents admitted to modifying their medication.…
FDA fights opioid abuse with industry guidance Measures to limit the abuse of opioid drugs have been issued by the US Food and Drug Administration in guidance for the pharmaceutical industry.…
FDA takes legal action against compounding pharmacyThe US Food and Drug Administration has taken legal action to prevent a compounding pharmacy from manufacturing or holding sterile drugs.…
Reformulated OxyContin reduces abuse but many addicts have switched to heroin Reformulation of OxyContin into an abuse-deterrent formula has reduced its illicit use but has caused people to switch to other opioid drugs, a US study finds.…
How the pharmaceutical industry is contributing to antimicrobial resistance Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…
